Over Thirty Months Scheme
Over Thirty Months Scheme (OTMS) was a significant agricultural policy implemented in the United Kingdom in response to the outbreak of Bovine Spongiform Encephalopathy (BSE), commonly known as mad cow disease. The scheme, introduced in 1996, aimed to prevent BSE from entering the human food chain by prohibiting the sale of beef from cattle aged over thirty months at the time of slaughter.
Background
BSE is a fatal neurodegenerative disease in cattle that affects the central nervous system, leading to death. It is believed to have spread through the practice of feeding cattle meat-and-bone meal that contained the remains of other cattle, which inadvertently created a cycle of infection. The link between BSE and variant Creutzfeldt-Jakob Disease (vCJD) in humans, a similar neurodegenerative disease, was established, raising public health concerns and leading to a crisis in the beef industry.
Implementation
The Over Thirty Months Scheme was part of a broader set of measures aimed at controlling the spread of BSE and restoring public confidence in beef products. Under the OTMS, cattle over thirty months of age were not allowed into the food supply. Instead, they were slaughtered and their carcasses destroyed. This measure was seen as necessary to reduce the risk of BSE-contaminated beef entering the human food chain.
Farmers were compensated for the loss of their animals, with the cost of the scheme funded by the European Union and the UK government. The scheme also included stringent regulations on animal feed, banning the use of meat-and-bone meal in feed for all farm animals.
Impact
The Over Thirty Months Scheme had a profound impact on the UK's cattle industry, leading to the slaughter of millions of cattle and significant financial costs. However, it played a crucial role in controlling the spread of BSE and restoring consumer confidence in beef products. The incidence of BSE in the UK significantly decreased following the implementation of the OTMS and other control measures.
Conclusion
The Over Thirty Months Scheme was a critical response to the BSE crisis, demonstrating the importance of swift and decisive action in the face of public health threats. It highlighted the need for rigorous food safety standards and the role of government intervention in managing such crises. The scheme was eventually phased out as the risk of BSE diminished, replaced by enhanced surveillance and testing programs for cattle.
This article is a agriculture stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD